T1	Participants 46 101	chronic hepatitis C resulting from intravenous drug use
T2	Participants 191 252	intravenous drug users (IVDUs) with chronic hepatitis C (CHC)
T3	Participants 553 580	Belgium and The Netherlands
T4	Participants 593 630	406 previously untreated CHC patients
T5	Participants 1766 1782	Benelux patients
T6	Participants 1985 2039	chronic hepatitis C patients who use intravenous drugs
